CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy
Sign Up to like & getrecommendations! Published in 2018 at "BMC Cancer"
DOI: 10.1186/s12885-018-4724-8
Abstract: BackgroundDoxorubicin-based chemotherapy is currently the most frequently used treatment for triple negative breast cancer (TNBC), yet the response rate is not high due to the lack of a biomarker allowing identification of responsive patients before… read more here.
Keywords: chemotherapy; biomarker; doxorubicin based; based chemotherapy ... See more keywords
The Effects of Doxorubicin-based Chemotherapy and Omega-3 Supplementation on Mouse Brain Lipids
Sign Up to like & getrecommendations! Published in 2019 at "Metabolites"
DOI: 10.3390/metabo9100208
Abstract: Chemotherapy-induced cognitive impairment affects ~30% of breast cancer survivors, but the effects on how chemotherapy impacts brain lipids, and how omega-3 polyunsaturated fatty acid supplementation may confer protection, is unknown. Ovariectomized mice were randomized to… read more here.
Keywords: chemotherapy; supplementation; brain lipids; doxorubicin based ... See more keywords